You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Neomycin sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for neomycin sulfate and what is the scope of freedom to operate?

Neomycin sulfate is the generic ingredient in thirteen branded drugs marketed by Pharmacia And Upjohn, X Gen Pharms, Pfizer, Adrastea Pharma, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Glaxosmithkline, Alcon, Watson Labs, Xgen Pharms, Monarch Pharms, Allergan, Merck, Savage Labs, Fougera, and Pharmaderm, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for neomycin sulfate. Four suppliers are listed for this compound.

Summary for neomycin sulfate
US Patents:0
Tradenames:13
Applicants:22
NDAs:31
Drug Master File Entries: 13
Finished Product Suppliers / Packagers: 4
Raw Ingredient (Bulk) Api Vendors: 99
Clinical Trials: 11
Patent Applications: 6,923
What excipients (inactive ingredients) are in neomycin sulfate?neomycin sulfate excipients list
DailyMed Link:neomycin sulfate at DailyMed
Recent Clinical Trials for neomycin sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vietstar Biomedical ResearchN/A
Huro Biotech Joint Stock CompanyN/A
Mahidol UniversityPhase 4

See all neomycin sulfate clinical trials

Pharmacology for neomycin sulfate
Medical Subject Heading (MeSH) Categories for neomycin sulfate

US Patents and Regulatory Information for neomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nostrum Labs Inc NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065468-001 Mar 29, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 060385-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 060365-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lannett NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 060607-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
X Gen Pharms NEO-FRADIN neomycin sulfate SOLUTION;ORAL 065010-001 May 23, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xgen Pharms NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 065106-001 Jan 31, 2006 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.